How many insider declarations has Carter Eric G filed?

Carter Eric G has filed 2 public insider declarations with SEC (Form 4).

What is Carter Eric G's role?

Carter Eric G's reported role is not specified by the regulator across the filings.

Which companies does Carter Eric G report trades for?

Carter Eric G reports trades for AEON Biopharma, Inc..

← Executives ★ Sign in to follow

CE

Carter Eric G

OFFICER

·SEC (Form 4)

AEON Biopharma, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Carter Eric G. Insider active across 1 company, notably AEON Biopharma, Inc.. In total, 2 disclosures have been recorded. History available since 31 August 2024. The latest transaction was filed on 31 August 2024 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Carter Eric G

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

AEON Biopharma, Inc. (US)

Declarations2 total

◆

Carter Eric G

DirectorExecutives17 Jun 2026AEON Biopharma, Inc.

0SEC ↗

222,684 sharesClass A Common StockSEC:0001104659-26-076509:0

◆

Carter Eric G

DirectorExecutives31 Aug 2024AEON Biopharma, Inc.

0SEC ↗

36,021 shares0Class A Common StockSEC:0001104659-24-097061:0

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

CE

Carter Eric G

OFFICER

·SEC (Form 4)

AEON Biopharma, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Carter Eric G. Insider active across 1 company, notably AEON Biopharma, Inc.. In total, 2 disclosures have been recorded. History available since 31 August 2024. The latest transaction was filed on 31 August 2024 (Attribution). Regulator: SEC (Form 4). All data is free.